Cholesterol

National Heart, Lung, and Blood InstituteUS$4.3mNational Institute of Diabetes and Digestive and Kidney DiseasesUS$953.4kNational Eye InstituteUS$698k12 grants since 2011

• Cholesterol reduction and cardiovascular risk in Type 1 diabetes

  National Heart, Lung, and Blood InstituteNew York University School of MedicineUS$616.7k2022–2027

• Cholesterol and inflammation Lowering via BEmpedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

  National Heart, Lung, and Blood InstituteUniversity of California Los AngelesUS$581.1k2022–2027

• Female protection from MASLD via bile acid regulation of cholesterol levels

  National Institute of Diabetes and Digestive and Kidney DiseasesUniversity of California Los AngelesUS$167.8k2026–2031

• Mechanisms of Cholesterol Induced Lymphatic Dysfunction: Can GLP-1R Agonism Improve Lymphatic Function in Obesity and Metabolic Syndrome?

  National Heart, Lung, and Blood InstituteTulane University of LouisianaUS$499.7k2026–2030

• Reducing Remnant Cholesterol and Managing Dyslipidemia with Human Milk Oligosaccharides

  National Heart, Lung, and Blood InstituteUniversity of UtahUS$651k2026–2030

• Interaction of alpha-crystallin with cholesterol bilayer domains in cataract formation

  National Eye InstituteBoise State UniversityUS$347k2019–2029

• Hepatic Rap1a in cholesterol homeostasis

  National Heart, Lung, and Blood InstituteColumbia University Health SciencesUS$632.9k2023–2027

• Cholesterol efflux, CHIP and inflammasome activation

  National Heart, Lung, and Blood InstituteColumbia University Health SciencesUS$604.5k2011–2027

• Regulation of successful optic nerve regeneration by the mevalonate/cholesterol pathway

  National Eye InstituteMedical College of WisconsinUS$351k2022–2027

• Effects of Cholesterol in Pancreatic Islets

  National Institute of Diabetes and Digestive and Kidney DiseasesSeattle Inst for Biomedical/clinical ResUS$430.8k2023–2027